These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2078948)

  • 41. Review: Clinical usefulness of ultrapure dialysate--recent evidence and perspectives.
    Masakane I
    Ther Apher Dial; 2006 Aug; 10(4):348-54. PubMed ID: 16911188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dialysis-associated adverse reactions with high-flux membranes and microbial contamination of liquid bicarbonate concentrate.
    Man NK; Ciancioni C; Faivre JM; Diab N; London G; Maret J; Wambergue FP
    Contrib Nephrol; 1988; 62():24-34. PubMed ID: 3359782
    [No Abstract]   [Full Text] [Related]  

  • 43. [Biocompatibility study--inflammable cytokine production by the extract from fiber membrane in human peripheral blood].
    Ikeda K
    Nihon Geka Gakkai Zasshi; 1994 Aug; 95(8):496-503. PubMed ID: 7969016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria.
    Lonnemann G; Behme TC; Lenzner B; Floege J; Schulze M; Colton CK; Koch KM; Shaldon S
    Kidney Int; 1992 Jul; 42(1):61-8. PubMed ID: 1635355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-1--its multiple biological effects and its association with hemodialysis.
    Dinarello CA
    Blood Purif; 1988; 6(3):164-72. PubMed ID: 3293622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of bicarbonate hemodialysis, hemodiafiltration, and acetate-free biofiltration on cytokine production.
    Higuchi T; Yamamoto C; Kuno T; Okada K; Soma M; Fukuda N; Nagura Y; Takahashi S; Matsumoto K
    Ther Apher Dial; 2004 Dec; 8(6):460-7. PubMed ID: 15663545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contamination of dialysis water and dialysate. A survey of 30 centers.
    Bambauer R; Schauer M; Jung WK; Daum V; Vienken J
    ASAIO J; 1994; 40(4):1012-6. PubMed ID: 7858320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cytokine mRNA expression in peripheral blood mononuclear cells from hemodialysis and CAPD patients].
    Takahashi T
    Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):179-85. PubMed ID: 7731106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokine production in haemodialysis.
    Memoli B
    Blood Purif; 1999; 17(2-3):149-58. PubMed ID: 10449873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gram-positive and gram-negative bacteria induce different patterns of cytokine production in human mononuclear cells irrespective of taxonomic relatedness.
    Skovbjerg S; Martner A; Hynsjö L; Hessle C; Olsen I; Dewhirst FE; Tham W; Wold AE
    J Interferon Cytokine Res; 2010 Jan; 30(1):23-32. PubMed ID: 20028205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [High-efficiency membranes and the dialysis solution].
    Agliata S; Airoldi G; Baroni A; Boschetti M; Schweiger K; Fortina F; Ragazzoni E; Cavagnino A
    Minerva Urol Nefrol; 1990; 42(1):39-42. PubMed ID: 2389221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Balance between cytokine production by peripheral blood mononuclear cells and reactive oxygen species production by monocytes in patients with chronic kidney disease.
    Sardenberg C; Suassuna P; Watanabe R; Cruz Andreoli MC; Aparecida Dalboni M; Faria Seabra V; Draibe SA; Cendoroglo Neto M; Jaber B
    Ren Fail; 2004 Nov; 26(6):673-81. PubMed ID: 15600259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
    Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
    Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
    Lonnemann G; Schindler R
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
    [No Abstract]   [Full Text] [Related]  

  • 55. Why and how to monitor bacterial contamination of dialysate?
    Pérez-García R; Rodríguez-Benítez PO
    Nephrol Dial Transplant; 2000 Jun; 15(6):760-4. PubMed ID: 10831624
    [No Abstract]   [Full Text] [Related]  

  • 56. [Role of tumor necrosis factor in hemodiafiltration].
    Tetta C; Segoloni G; Fidelio T; Licata C; Sancipriano GP; Iacono G; Ragni R; Vercellone A
    Minerva Urol Nefrol; 1991; 43(3):181-3. PubMed ID: 1817342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
    Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
    Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defective interleukin-10 synthesis by peripheral blood mononuclear cells among hemodialysis patients.
    Perianayagam MC; Jaber BL; Guo D; King AJ; Pereira BJ; Balakrishnan VS
    Blood Purif; 2002; 20(6):543-50. PubMed ID: 12566670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution.
    Martis L; Patel M; Giertych J; Mongoven J; Taminne M; Perrier MA; Mendoza O; Goud N; Costigan A; Denjoy N; Verger C; Owen WF
    Lancet; 2005 Feb 12-18; 365(9459):588-94. PubMed ID: 15708102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis.
    Van Biesen W; Vanholder R; Schepers E; Glorieux G; Dhondt A; Eloot S
    Contrib Nephrol; 2017; 191():168-177. PubMed ID: 28910800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.